Center of Neuropharmacology, Department of Pharmacological Sciences, Università degli Studi di Milano, Via Balzaretti 9, 20133 Milan, Italy.
Eur Neuropsychopharmacol. 2013 Feb;23(2):160-70. doi: 10.1016/j.euroneuro.2012.04.005. Epub 2012 May 18.
Repeated administration of the indirect dopamine receptor agonist amphetamine (AMPH) produces robust locomotor sensitization and additional behavioral abnormalities. Accumulating evidence suggests that the developmental timing of drug exposure can critically influence this effect. The present study compared the consequences of withdrawal from repeated AMPH exposure in adolescence and adulthood on information processing and locomotor sensitization in C57BL/6 mice. Animals were injected daily with AMPH (1 or 2.5 mg/kg) or vehicle on 7 consecutive days starting either from postnatal day 35 to 42, or from postnatal day 70 to 77, following which they were given a 4 week withdrawal period before behavioral and pharmacological testing commenced. We found that withdrawal from the higher dose of AMPH (2.5 mg/kg/day) given either in adolescence or adulthood similarly disrupted selective associative learning as measured by the latent inhibition paradigm. None of the AMPH withdrawal groups displayed alterations in sensorimotor gating in the form of prepulse inhibition. Withdrawal from adult AMPH exposure at both doses induced marked locomotor sensitization, whereas adolescent pre-treatment with the higher (2.5 mg/kg/day) but not lower (1 mg/kg/day) dose of AMPH potentiated the locomotor-enhancing effects of acute AMPH re-challenge. Our study suggests that withdrawal from repeated AMPH exposure in adolescence and adulthood has similar consequences on selective associative learning, but the two manipulations differ with respect to their efficacy to induce long-term locomotor sensitization to the drug. The latter finding supports the hypothesis that the precise developmental timing determines, at least in part, the impact on long-term dopamine-associated sensitization processes.
反复给予间接多巴胺受体激动剂安非他命(AMPH)会产生强烈的运动敏化和其他行为异常。越来越多的证据表明,药物暴露的发展时间可以极大地影响这种效果。本研究比较了青春期和成年期反复 AMPH 暴露戒断对 C57BL/6 小鼠信息处理和运动敏化的影响。动物每天接受 AMPH(1 或 2.5mg/kg)或载体注射,连续 7 天,从出生后第 35 天至 42 天,或从出生后第 70 天至 77 天开始,然后进行 4 周的戒断期,然后开始行为和药理学测试。我们发现,无论是在青春期还是成年期给予较高剂量的 AMPH(2.5mg/kg/天)戒断,都会类似地破坏潜伏抑制范式所测量的选择性联想学习。没有一个 AMPH 戒断组显示出感觉运动门控的变化,表现为预脉冲抑制。两种剂量的成年期 AMPH 暴露戒断均诱导明显的运动敏化,而青春期用较高剂量(2.5mg/kg/天)而不是较低剂量(1mg/kg/天)预处理 AMPH 增强了急性 AMPH 再挑战的运动增强作用。我们的研究表明,青春期和成年期反复 AMPH 暴露戒断对选择性联想学习有类似的影响,但这两种处理在诱导对药物的长期运动敏化方面存在差异。后一种发现支持这样一种假设,即精确的发展时间至少部分决定了长期多巴胺相关敏化过程的影响。